TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1570106
log Bayes Factor = <0.0001
Chromosome 14   position 68,813,115  (GRCh37) Explore rs1570106 on Ensembl!
Variant rs1570106 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T40.2 Other opioids
0.000 0.967 0.033
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.968 0.032
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.969 0.031
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.969 0.031
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.970 0.030
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.972 0.028
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.972 0.028
T40.6 Other and unspecified narcotics
0.000 0.973 0.027
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.974 0.026
T40.5 Cocaine
0.000 0.974 0.026
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.974 0.026
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.975 0.025
T40.1 Heroin
0.000 0.975 0.025
T42.4 Benzodiazepines
0.000 0.975 0.025
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.975 0.025
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.975 0.025
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.975 0.024
T36 Poisoning by systemic antibiotics
0.000 0.976 0.024
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.976 0.024
Z57.2 Occupational exposure to dust
0.000 0.976 0.024
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.976 0.024
T46.1 Calcium-channel blockers
0.000 0.976 0.024
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.976 0.023
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.977 0.023
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.977 0.023
T40.8 Lysergide [LSD]
0.000 0.977 0.023
T40.7 Cannabis (derivatives)
0.000 0.977 0.023
T40.3 Methadone
0.000 0.977 0.023
T40.0 Opium
0.000 0.977 0.023
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.977 0.023
T42.0 Hydantoin derivatives
0.000 0.977 0.023
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.977 0.023
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.978 0.022
K31.9 Disease of stomach and duodenum, unspecified
0.000 0.978 0.022
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.978 0.022
T42.2 Succinimides and oxazolidinediones
0.000 0.978 0.022
Z57 Occupational exposure to risk-factors
0.000 0.978 0.022
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.978 0.022
T42.3 Barbiturates
0.000 0.979 0.021
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.979 0.021
T47.2 Stimulant laxatives
0.000 0.979 0.021
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.979 0.021
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.979 0.021
T45.5 Anticoagulants
0.000 0.979 0.021
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.979 0.021
T47.4 Other laxatives
0.000 0.979 0.020
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.979 0.020
T46.7 Peripheral vasodilators
0.000 0.979 0.020
T47.6 Antidiarrhoeal drugs
0.000 0.980 0.020
T36.4 Tetracyclines
0.000 0.980 0.020
T38.0 Glucocorticoids and synthetic analogues
0.000 0.980 0.020
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.980 0.020
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.980 0.020
T50.8 Diagnostic agents
0.000 0.981 0.019
T38.5 Other oestrogens and progestogens
0.000 0.981 0.019
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances
0.000 0.981 0.019
T38.9 Other and unspecified hormone antagonists
0.000 0.981 0.019
T38.7 Androgens and anabolic congeners
0.000 0.981 0.019
T38.4 Oral contraceptives
0.000 0.981 0.019
T38.2 Antithyroid drugs
0.000 0.981 0.019
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.981 0.019
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.981 0.019
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.981 0.019
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.981 0.018
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.981 0.018
T47.7 Emetics
0.000 0.981 0.018
T47.5 Digestants
0.000 0.981 0.018
T47.3 Saline and osmotic laxatives
0.000 0.981 0.018
T50.1 Loop [high-ceiling] diuretics
0.000 0.981 0.018
Z60.2 Living alone
0.000 0.981 0.019
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.981 0.018
T45.2 Vitamins, not elsewhere classified
0.000 0.981 0.018
T39.4 Antirheumatics, not elsewhere classified
0.000 0.982 0.018
T39.2 Pyrazolone derivatives
0.000 0.982 0.018
Z60 Problems related to social environment
0.000 0.982 0.018
T36.3 Macrolides
0.000 0.982 0.018
Z57.3 Occupational exposure to other air contaminants
0.000 0.982 0.018
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.982 0.018
Z63 Other problems related to primary support group, including family circumstances
0.000 0.982 0.018
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.982 0.018
T45.8 Other primarily systemic and haematological agents
0.000 0.982 0.018
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.982 0.018
T45.6 Fibrinolysis-affecting drugs
0.000 0.982 0.018
T45.4 Iron and its compounds
0.000 0.982 0.018
T45.3 Enzymes, not elsewhere classified
0.000 0.982 0.018
T50.7 Analeptics and opioid receptor antagonists
0.000 0.982 0.018
T50.5 Appetite depressants
0.000 0.982 0.018
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.982 0.018
T50.0 Mineralocorticoids and their antagonists
0.000 0.982 0.018
Z57.5 Occupational exposure to toxic agents in other industries
0.000 0.982 0.018
T36.9 Systemic antibiotic, unspecified
0.000 0.982 0.018
T36.7 Antifungal antibiotics, systemically used
0.000 0.982 0.018
T36.6 Rifamycins
0.000 0.982 0.018
T36.5 Aminoglycosides
0.000 0.982 0.018
T36.2 Chloramphenicol group
0.000 0.982 0.018
Z63.7 Other stressful life events affecting family and household
0.000 0.982 0.018
T49.9 Topical agent, unspecified
0.000 0.983 0.017
T49.8 Other topical agents
0.000 0.983 0.017
T49.7 Dental drugs, topically applied
0.000 0.983 0.017
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.983 0.017
T49.5 Ophthalmological drugs and preparations
0.000 0.983 0.017
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.983 0.017
T49.3 Emollients, demulcents and protectants
0.000 0.983 0.017
T49.2 Local astringents and local detergents
0.000 0.983 0.017
T49.1 Antipruritics
0.000 0.983 0.017
T47.0 Histamine H(2)-receptor antagonists
0.000 0.983 0.017
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.983 0.017
T50.4 Drugs affecting uric acid metabolism
0.000 0.983 0.017
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.983 0.017
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.983 0.017
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.983 0.017
T41.2 Other and unspecified general anaesthetics
0.000 0.983 0.017
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.983 0.017
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.983 0.017
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.983 0.017
T37.5 Antiviral drugs
0.000 0.983 0.017
T37.4 Anthelminthics
0.000 0.983 0.017
T37.3 Other antiprotozoal drugs
0.000 0.983 0.017
T37.1 Antimycobacterial drugs
0.000 0.983 0.017
T37.0 Sulphonamides
0.000 0.983 0.017
T41.5 Therapeutic gases
0.000 0.983 0.017
T41.4 Anaesthetic, unspecified
0.000 0.983 0.017
T41.3 Local anaesthetics
0.000 0.983 0.017
T41.1 Intravenous anaesthetics
0.000 0.983 0.017
T41.0 Inhaled anaesthetics
0.000 0.983 0.017
Z57.8 Occupational exposure to other risk-factors
0.000 0.983 0.017
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.983 0.016
Z59 Problems related to housing and economic circumstances
0.000 0.984 0.016
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.984 0.016
Z57.9 Occupational exposure to unspecified risk-factor
0.000 0.984 0.016
Z57.7 Occupational exposure to vibration
0.000 0.984 0.016
Z57.6 Occupational exposure to extreme temperature
0.000 0.984 0.016
Z57.4 Occupational exposure to toxic agents in agriculture
0.000 0.984 0.016
Z57.1 Occupational exposure to radiation
0.000 0.984 0.016
Z57.0 Occupational exposure to noise
0.000 0.984 0.016
T36.0 Penicillins
0.000 0.984 0.016
T45.0 Antiallergic and antiemetic drugs
0.000 0.984 0.016
T38.1 Thyroid hormones and substitutes
0.000 0.984 0.015
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.984 0.015
T48.4 Expectorants
0.000 0.984 0.015
T48.3 Antitussives
0.000 0.984 0.015
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.984 0.015
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.984 0.015
T48.0 Oxytocic drugs
0.000 0.984 0.015
T36.8 Other systemic antibiotics
0.000 0.984 0.015
Z61 Problems related to negative life events in childhood
0.000 0.984 0.015
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.985 0.015
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.985 0.015
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.985 0.015
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.985 0.015
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.985 0.015
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.985 0.015
T44.0 Anticholinesterase agents
0.000 0.985 0.015
Z63.4 Disappearance and death of family member
0.000 0.985 0.015
T48.5 Anti-common-cold drugs
0.000 0.985 0.015
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.985 0.015
Z63.6 Dependent relative needing care at home
0.000 0.985 0.015
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.985 0.014
Z59.8 Other problems relating to housing and economic circumstances
0.000 0.985 0.015
Z60.9 Problem related to social environment, unspecified
0.000 0.986 0.014
Z62 Other problems related to upbringing
0.000 0.986 0.014
Z55 Problems related to education and literacy
0.000 0.986 0.014
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group
0.000 0.986 0.014
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.986 0.014
T42.1 Iminostilbenes
0.000 0.986 0.013
Z60.5 Target of perceived adverse discrimination and persecution
0.000 0.987 0.013
Z60.4 Social exclusion and rejection
0.000 0.987 0.013
Z60.3 Acculturation difficulty
0.000 0.987 0.013
Z60.1 Atypical parenting situation
0.000 0.987 0.013
Z60.0 Problems of adjustment to life-cycle transitions
0.000 0.987 0.013
Z63.9 Problem related to primary support group, unspecified
0.000 0.987 0.013
Z63.3 Absence of family member
0.000 0.987 0.013
Z63.2 Inadequate family support
0.000 0.987 0.013
Z63.1 Problems in relationship with parents and in-laws
0.000 0.987 0.013
Z59.4 Lack of adequate food
0.000 0.987 0.013
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.987 0.013
Z59.1 Inadequate housing
0.000 0.988 0.012
Z59.9 Problem relating to housing and economic circumstances, unspecified
0.000 0.988 0.012
Z65 Problems related to other psychosocial circumstances
0.000 0.988 0.012
Z59.7 Insufficient social insurance and welfare support
0.000 0.988 0.012
Z59.6 Low income
0.000 0.988 0.012
Z59.5 Extreme poverty
0.000 0.988 0.012
Z59.3 Problems related to living in residential institution
0.000 0.988 0.012
Z64 Problems related to certain psychosocial circumstances
0.000 0.988 0.012
Z63.0 Problems in relationship with spouse or partner
0.000 0.988 0.012
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group
0.000 0.988 0.012
Z58 Problems related to physical environment
0.000 0.988 0.012
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.000 0.988 0.012
Z59.0 Homelessness
0.000 0.989 0.011
Z61.9 Negative life events in childhood, unspecified
0.000 0.989 0.011
Z61.7 Personal frightening experience in childhood
0.000 0.989 0.011
Z61.3 Events resulting in loss of self-esteem in childhood
0.000 0.989 0.011
Z61.2 Altered pattern of family relationships in childhood
0.000 0.989 0.011
Z61.1 Removal from home in childhood
0.000 0.989 0.011
Z61.0 Loss of love relationship in childhood
0.000 0.989 0.011
Z02.8 Other examinations for administrative purposes
0.000 0.989 0.011
Z59.2 Discord with neighbours, lodgers and landlord
0.000 0.989 0.011
Z56 Problems related to employment and unemployment
0.000 0.989 0.011
Z60.8 Other problems related to social environment
0.000 0.989 0.011
Z61.8 Other negative life events in childhood
0.000 0.989 0.010
Z63.8 Other specified problems related to primary support group
0.000 0.989 0.010
Z55.9 Problems relating to education and literacy, unspecified
0.000 0.990 0.010
Z55.8 Other problems relating to education and literacy
0.000 0.990 0.010
Z55.4 Educational maladjustment and discord with teachers and classmates
0.000 0.990 0.010
Z55.3 Underachievement in school
0.000 0.990 0.010
Z55.2 Failed examinations
0.000 0.990 0.010
Z55.1 Schooling unavailable and unattainable
0.000 0.990 0.010
Z55.0 Illiteracy and low-level literacy
0.000 0.990 0.010
Z62.9 Problem related to upbringing, unspecified
0.000 0.990 0.010
Z62.8 Other specified problems related to upbringing
0.000 0.990 0.010
Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing
0.000 0.990 0.010
Z62.5 Other problems related to neglect in upbringing
0.000 0.990 0.010
Z62.4 Emotional neglect of child
0.000 0.990 0.010
Z62.3 Hostility towards and scapegoating of child
0.000 0.990 0.010
Z62.2 Institutional upbringing
0.000 0.990 0.010
Z62.1 Parental overprotection
0.000 0.990 0.010
Z62.0 Inadequate parental supervision and control
0.000 0.990 0.010
Z61.6 Problems related to alleged physical abuse of child
0.000 0.990 0.010
Z63.5 Disruption of family by separation and divorce
0.000 0.990 0.010
J45.9 Asthma, unspecified
0.000 0.991 0.009
Z65.5 Exposure to disaster, war and other hostilities
0.000 0.991 0.009
Z65.4 Victim of crime and terrorism
0.000 0.991 0.009
Z65.2 Problems related to release from prison
0.000 0.991 0.009
Z65.1 Imprisonment and other incarceration
0.000 0.991 0.009
Z65.0 Conviction in civil and criminal proceedings without imprisonment
0.000 0.991 0.009
Z64.4 Discord with counsellors
0.000 0.991 0.009
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful
0.000 0.991 0.009
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
0.000 0.991 0.009
Z64.1 Problems related to multiparity
0.000 0.991 0.009
Z58.8 Other problems related to physical environment
0.000 0.991 0.009
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.991 0.009
Z65.9 Problem related to unspecified psychosocial circumstances
0.000 0.991 0.008
T40.4 Other synthetic narcotics
0.002 0.991 0.006
Z58.9 Problem related to physical environment, unspecified
0.000 0.991 0.008
Z58.6 Inadequate drinking-water supply
0.000 0.991 0.008
Z58.4 Exposure to radiation
0.000 0.991 0.008
Z58.3 Exposure to soil pollution
0.000 0.991 0.008
Z58.2 Exposure to water pollution
0.000 0.991 0.008
Z58.0 Exposure to noise
0.000 0.991 0.008
Z65.8 Other specified problems related to psychosocial circumstances
0.000 0.991 0.008
Z56.7 Other and unspecified problems related to employment
0.000 0.992 0.008
Z56.5 Uncongenial work
0.000 0.992 0.008
Z56.2 Threat of job loss
0.000 0.992 0.008
Z56.1 Change of job
0.000 0.992 0.008
Z65.3 Problems related to other legal circumstances
0.000 0.992 0.008
Z56.3 Stressful work schedule
0.000 0.992 0.008
Z58.7 Exposure to tobacco smoke
0.000 0.992 0.008
Z58.5 Exposure to other pollution
0.000 0.992 0.008
A87.9 Viral meningitis, unspecified
0.000 0.992 0.008
Z56.0 Unemployment, unspecified
0.000 0.992 0.008
T39.0 Salicylates
0.000 0.992 0.008
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)
0.000 0.992 0.008
Z58.1 Exposure to air pollution
0.000 0.992 0.007
Z56.4 Discord with boss and workmates
0.000 0.992 0.007
Z56.6 Other physical and mental strain related to work
0.000 0.993 0.007
K62.8 Other specified diseases of anus and rectum
0.007 0.993 0.000
K92.1 Melaena
0.007 0.993 0.000
Z64.0 Problems related to unwanted pregnancy
0.000 0.993 0.006
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.993 0.006
T43.9 Psychotropic drug, unspecified
0.000 0.994 0.006
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.994 0.006
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.994 0.006
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.994 0.006
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.994 0.006
T43.6 Psychostimulants with abuse potential
0.000 0.994 0.006
J33.8 Other polyp of sinus
0.000 0.995 0.005
M22.4 Chondromalacia patellae
0.005 0.995 0.000
Z02 Examination and encounter for administrative purposes
0.000 0.995 0.005
S06.6 Traumatic subarachnoid haemorrhage
0.000 0.995 0.005
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.995 0.004
T43.2 Other and unspecified antidepressants
0.000 0.995 0.004
L40.5 Arthropathic psoriasis
0.000 0.996 0.004
M48.09 Spinal stenosis (Site unspecified)
0.000 0.996 0.004
R26.8 Other and unspecified abnormalities of gait and mobility
0.000 0.996 0.004
A87 Viral meningitis
0.000 0.996 0.004
M48.02 Spinal stenosis (Cervical region)
0.000 0.996 0.004
L42 Pityriasis rosea
0.000 0.996 0.004
Z02.9 Examination for administrative purposes, unspecified
0.000 0.996 0.004
Z02.7 Issue of medical certificate
0.000 0.996 0.004
Z02.6 Examination for insurance purposes
0.000 0.996 0.004
Z02.5 Examination for participation in sport
0.000 0.996 0.004
Z02.4 Examination for driving licence
0.000 0.996 0.004
Z02.3 Examination for recruitment to armed forces
0.000 0.996 0.004
Z02.2 Examination for admission to residential institution
0.000 0.996 0.004
Z02.1 Pre-employment examination
0.000 0.996 0.004
Z02.0 Examination for admission to educational institution
0.000 0.996 0.004
J45 Asthma
0.000 0.996 0.004
X41.9 Unspecified place
0.000 0.996 0.004
L40 Psoriasis
0.000 0.996 0.004
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)
0.000 0.996 0.003
T39.1 4-Aminophenol derivatives
0.000 0.997 0.003
L40.1 Generalised pustular psoriasis
0.000 0.997 0.003
J33.0 Polyp of nasal cavity
0.000 0.997 0.003
L40-L45 Papulosquamous disorders
0.000 0.997 0.003
E53.8 Deficiency of other specified B group vitamins
0.000 0.997 0.003
A87.8 Other viral meningitis
0.000 0.997 0.003
A87.1 Adenoviral meningitis
0.000 0.997 0.003
A87.0 Enteroviral meningitis
0.000 0.997 0.003
L43 Lichen planus
0.000 0.997 0.003
J45.8 Mixed asthma
0.000 0.997 0.003
L43.8 Other lichen planus
0.000 0.997 0.003
A87.2 Lymphocytic choriomeningitis
0.000 0.997 0.003
L40.8 Other psoriasis
0.000 0.997 0.003
S06.00 Concussion (without open intracranial wound)
0.000 0.997 0.003
J33 Nasal polyp
0.000 0.997 0.003
J45.1 Nonallergic asthma
0.000 0.997 0.003
L40.4 Guttate psoriasis
0.000 0.997 0.003
V18.2 Unspecified pedal cyclist injured in nontraffic accident
0.003 0.997 0.000
L40.2 Acrodermatitis continua
0.000 0.997 0.003
M22.8 Other disorders of patella
0.003 0.997 0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.000 0.997 0.003
E55.9 Vitamin D deficiency, unspecified
0.003 0.997 0.000
M22 Disorders of patella
0.003 0.997 0.000
L40.3 Pustulosis palmaris et plantaris
0.000 0.997 0.003
L44 Other papulosquamous disorders
0.000 0.997 0.003
R26.3 Immobility
0.000 0.997 0.003
L43.9 Lichen planus, unspecified
0.000 0.997 0.003
L41 Parapsoriasis
0.000 0.997 0.003
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.997 0.003
S06.0 Concussion
0.000 0.997 0.003
I49.5 Sick sinus syndrome
0.000 0.997 0.003
L43.3 Subacute (active) lichen planus
0.000 0.997 0.002
L43.2 Lichenoid drug reaction
0.000 0.997 0.002
L43.1 Bullous lichen planus
0.000 0.997 0.002
C67.9 Bladder, unspecified
0.003 0.997 0.000
J33.1 Polypoid sinus degeneration
0.000 0.997 0.003
L43.0 Hypertrophic lichen planus
0.000 0.997 0.002
M48.0 Spinal stenosis
0.000 0.997 0.003
G83.4 Cauda equina syndrome
0.000 0.997 0.003
L40.0 Psoriasis vulgaris
0.000 0.997 0.002
N42.8 Other specified disorders of prostate
0.000 0.997 0.003
S62.80 Fracture of other and unspecified parts of wrist and hand (closed)
0.003 0.997 0.000
M34.9 Systemic sclerosis, unspecified
0.000 0.997 0.003
R26 Abnormalities of gait and mobility
0.000 0.997 0.003
T81.3 Disruption of operation wound, not elsewhere classified
0.003 0.997 0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)
0.000 0.998 0.002
V18.0 Driver injured in nontraffic accident
0.002 0.998 0.000
S06 Intracranial injury
0.000 0.998 0.002
V18 Pedal cyclist injured in noncollision transport accident
0.002 0.998 0.000
C25.9 Pancreas, unspecified
0.000 0.998 0.002
L98.8 Other specified disorders of skin and subcutaneous tissue
0.002 0.998 0.000
Y84.2 Radiological procedure and radiotherapy
0.000 0.998 0.002
L44.0 Pityriasis rubra pilaris
0.000 0.998 0.002
X41.0 Home
0.000 0.998 0.002
X41.8 Other specified place
0.000 0.998 0.002
X41.7 Farm
0.000 0.998 0.002
X41.6 Industrial and construction area
0.000 0.998 0.002
X41.5 Trade and service area
0.000 0.998 0.002
X41.4 Street and highway
0.000 0.998 0.002
X41.3 Sports and athletics area
0.000 0.998 0.002
X41.1 Residential institution
0.000 0.998 0.002
M22.1 Recurrent subluxation of patella
0.002 0.998 0.000
M22.9 Disorder of patella, unspecified
0.002 0.998 0.000
X41.2 School, other institution and public administrative area
0.000 0.998 0.002
L44.9 Papulosquamous disorder, unspecified
0.000 0.998 0.002
L44.8 Other specified papulosquamous disorders
0.000 0.998 0.002
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.998 0.002
L44.3 Lichen ruber moniliformis
0.000 0.998 0.002
L44.2 Lichen striatus
0.000 0.998 0.002
L44.1 Lichen nitidus
0.000 0.998 0.002
L41.9 Parapsoriasis, unspecified
0.000 0.998 0.002
L41.8 Other parapsoriasis
0.000 0.998 0.002
L41.5 Retiform parapsoriasis
0.000 0.998 0.002
L41.4 Large plaque parapsoriasis
0.000 0.998 0.002
L41.3 Small plaque parapsoriasis
0.000 0.998 0.002
L41.2 Lymphomatoid papulosis
0.000 0.998 0.002
L41.1 Pityriasis lichenoides chronica
0.000 0.998 0.002
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.998 0.002
X40-X49 Accidental poisoning by and exposure to noxious substances
0.000 0.998 0.002
S06.01 Concussion (with open intracranial wound)
0.000 0.998 0.002
M48.05 Spinal stenosis (Thoracolumbar region)
0.000 0.998 0.002
R26.0 Ataxic gait
0.000 0.998 0.002
X45 Accidental poisoning by and exposure to alcohol
0.000 0.998 0.002
M48.03 Spinal stenosis (Cervicothoracic region)
0.000 0.998 0.002
M48.01 Spinal stenosis (Occipito-atlanto-axial region)
0.000 0.998 0.002
R49.0 Dysphonia
0.000 0.998 0.002
V18.1 Passenger injured in nontraffic accident
0.002 0.998 0.000
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.000 0.998 0.002
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified
0.000 0.998 0.002
M22.3 Other derangements of patella
0.002 0.998 0.000
X45.0 Home
0.000 0.998 0.002
M22.2 Patellofemoral disorders
0.002 0.998 0.000
R23.8 Other and unspecified skin changes
0.000 0.998 0.002
X42.2 School, other institution and public administrative area
0.000 0.998 0.002
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.000 0.998 0.002
E05.0 Thyrotoxicosis with diffuse goitre
0.002 0.998 0.000
R26.1 Paralytic gait
0.000 0.998 0.002
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
0.000 0.998 0.002
K65.0 Acute peritonitis
0.002 0.998 0.000
S06.7 Intracranial injury with prolonged coma
0.000 0.998 0.002
V18.5 Passenger injured in traffic accident
0.002 0.998 0.000
M34.8 Other forms of systemic sclerosis
0.000 0.998 0.002
S06.4 Epidural haemorrhage
0.000 0.998 0.002
M48.04 Spinal stenosis (Thoracic region)
0.000 0.998 0.002
R61.9 Hyperhidrosis, unspecified
0.000 0.998 0.002
C18.3 Hepatic flexure
0.000 0.998 0.002
S06.3 Focal brain injury
0.000 0.998 0.002
V18.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.998 0.000
V18.4 Driver injured in traffic accident
0.002 0.998 0.000
N94.1 Dyspareunia
0.002 0.998 0.000
S06.5 Traumatic subdural haemorrhage
0.000 0.998 0.002
A80-A89 Viral infections of the central nervous system
0.000 0.998 0.002
X47 Accidental poisoning by and exposure to other gases and vapours
0.000 0.998 0.002
X41.08 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified , Home ,While engaged in other specified activities
0.000 0.998 0.002
J45.0 Predominantly allergic asthma
0.000 0.998 0.002
S06.8 Other intracranial injuries
0.000 0.998 0.002
S06.1 Traumatic cerebral oedema
0.000 0.998 0.002
M34 Systemic sclerosis
0.000 0.998 0.002
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
0.000 0.998 0.002
M22.10 Recurrent subluxation of patella, unspecified knee
0.002 0.998 0.000
M22.0 Recurrent dislocation of patella
0.002 0.998 0.000
C09.9 Tonsil, unspecified
0.000 0.998 0.002
X44.2 School, other institution and public administrative area
0.000 0.998 0.002
X43 Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system
0.000 0.998 0.002
X48 Accidental poisoning by and exposure to pesticides
0.000 0.998 0.002
X46 Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
0.000 0.998 0.002
X40 Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
0.000 0.998 0.002
H00.0 Hordeolum and other deep inflammation of eyelid
0.002 0.998 0.000
M34.1 CR(E)ST syndrome
0.000 0.998 0.002
S06.9 Intracranial injury, unspecified
0.000 0.998 0.002
E53 Deficiency of other B group vitamins
0.000 0.998 0.002
X42.9 Unspecified place
0.000 0.998 0.002
X42.0 Home
0.000 0.998 0.002
X42.8 Other specified place
0.000 0.998 0.002
X42.7 Farm
0.000 0.998 0.002
X42.6 Industrial and construction area
0.000 0.998 0.002
X42.5 Trade and service area
0.000 0.998 0.002
X42.4 Street and highway
0.000 0.998 0.002
X42.3 Sports and athletics area
0.000 0.998 0.002
X42.1 Residential institution
0.000 0.998 0.002
X45.9 Unspecified place
0.000 0.998 0.002
X45.8 Other specified place
0.000 0.998 0.002
X45.7 Farm
0.000 0.998 0.002
X45.6 Industrial and construction area
0.000 0.998 0.002
X45.5 Trade and service area
0.000 0.998 0.002
X45.4 Street and highway
0.000 0.998 0.002
X45.3 Sports and athletics area
0.000 0.998 0.002
X45.2 School, other institution and public administrative area
0.000 0.998 0.002
X45.1 Residential institution
0.000 0.998 0.002
W22.9 Unspecified place
0.002 0.998 0.000
H00.1 Chalazion
0.002 0.998 0.000
M34.0 Progressive systemic sclerosis
0.000 0.998 0.002
X44.9 Unspecified place
0.000 0.998 0.002
X44.0 Home
0.000 0.998 0.002
X44.8 Other specified place
0.000 0.998 0.002
X44.7 Farm
0.000 0.998 0.002
X44.6 Industrial and construction area
0.000 0.998 0.002
X44.5 Trade and service area
0.000 0.998 0.002
X44.4 Street and highway
0.000 0.998 0.002
X44.3 Sports and athletics area
0.000 0.998 0.002
X44.1 Residential institution
0.000 0.998 0.002
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.998 0.002
M19.07 Primary arthrosis of other joints (Ankle and foot)
0.000 0.998 0.002
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)
0.000 0.998 0.001
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)
0.000 0.998 0.001
X47.9 Unspecified place
0.000 0.998 0.002
X47.0 Home
0.000 0.998 0.002
X49.9 Unspecified place
0.000 0.998 0.002
S06.41 Epidural haemorrhage (with open intracranial wound)
0.000 0.998 0.002
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.998 0.002
S06.31 Focal brain injury (with open intracranial wound)
0.000 0.998 0.001
S06.40 Epidural haemorrhage (without open intracranial wound)
0.000 0.998 0.002
V18.49 Pedal cyclist injured in noncollision transport accident; driver injured in traffic accident ; during unspecified activity
0.001 0.998 0.000
V18.99 Pedal cyclist injured in noncollision transport accident; unspecified pedal cyclist injured in traffic accident; during unspecified activity
0.001 0.998 0.000
X47.8 Other specified place
0.000 0.998 0.002
Z80.9 Family history of malignant neoplasm, unspecified
0.002 0.998 0.000
A81 Atypical virus infections of central nervous system
0.000 0.998 0.002
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)
0.000 0.998 0.001
G83.8 Other specified paralytic syndromes
0.000 0.998 0.002
V18.3 Person injured while boarding or alighting
0.001 0.998 0.000
A88 Other viral infections of central nervous system, not elsewhere classified
0.000 0.998 0.002
A85 Other viral encephalitis, not elsewhere classified
0.000 0.998 0.002
A84 Tick-borne viral encephalitis
0.000 0.998 0.002
A83 Mosquito-borne viral encephalitis
0.000 0.998 0.002
A82 Rabies
0.000 0.998 0.002
A91 Dengue haemorrhagic fever
0.000 0.998 0.002
A90 Dengue fever [classical dengue]
0.000 0.998 0.002
A89 Unspecified viral infection of central nervous system
0.000 0.998 0.002
A86 Unspecified viral encephalitis
0.000 0.998 0.002
S06.11 Traumatic cerebral oedema (with open intracranial wound)
0.000 0.998 0.001
S06.81 Other intracranial injuries (with open intracranial wound)
0.000 0.998 0.001
H20.8 Other iridocyclitis
0.000 0.998 0.002
M34.2 Systemic sclerosis induced by drugs and chemicals
0.000 0.998 0.002
X47.7 Farm
0.000 0.998 0.001
X47.5 Trade and service area
0.000 0.998 0.001
X47.4 Street and highway
0.000 0.998 0.001
X47.3 Sports and athletics area
0.000 0.998 0.001
X47.2 School, other institution and public administrative area
0.000 0.998 0.001
X47.1 Residential institution
0.000 0.998 0.001
K25.3 Acute without haemorrhage or perforation
0.002 0.998 0.000
S06.2 Diffuse brain injury
0.000 0.998 0.002
X49.4 Street and highway
0.000 0.998 0.001
X49.0 Home
0.000 0.998 0.001
X49.8 Other specified place
0.000 0.998 0.001
X49.7 Farm
0.000 0.998 0.001
X49.3 Sports and athletics area
0.000 0.998 0.001
X49.2 School, other institution and public administrative area
0.000 0.998 0.001
X49.1 Residential institution
0.000 0.998 0.001
A80 Acute poliomyelitis
0.000 0.998 0.001
X43.9 Unspecified place
0.000 0.998 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.